300028207055: INSULIN LISPRO INJECTION.
The INSULIN LISPRO INJECTION is a the manufacturer industrial component. Key specifications include features_provided: UNIT DOSE, primary_container_type: VIAL INJECTOR UNIT, primary_container_content_quantity: 3.0 MILLILITERS, active_medicament_medicinal_strength: 100.0 MILLILITERS INSULIN ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: LYUMJEV 100 UNITS/ML. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-717-2028, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| features_provided | UNIT DOSE |
| primary_container_type | VIAL INJECTOR UNIT |
| total_primary_container_quantity | 3 |
| primary_container_content_quantity | 3.0 MILLILITERS |
| active_medicament_medicinal_strength | 100.0 MILLILITERS INSULIN ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | LYUMJEV 100 UNITS/ML |
| NSN | 6505-01-717-2028 |
| PRIMARY CONTAINER CONTENT QUANTITY | 3.0 MILLILITERS |
| FEATURES PROVIDED | UNIT DOSE |
| PRIMARY CONTAINER TYPE | VIAL INJECTOR UNIT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LYUMJEV 100 UNITS/ML |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.0 MILLILITERS INSULIN ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 3 |